Practice question

Answer the question and get instant feedback.

Moderate"ATS/IDSA (2019) recommends in healthy outpatients without comorbidities: amoxicillin (1 g TID) or doxycycline; macrolide monotherapy only where pneumococcal resistance <25%. A: Resistance often >25%. C/D/E: Broader therapy reserved for comorbidities or inpatient care."Respiratory Medicine"easy"

A 55-year-old with new community-acquired pneumonia (CAP), no comorbidities and no MRSA/Pseudomonas risk. Best outpatient empiric regimen per US guideline?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.